medigraphic.com
ISSN 1561-297X (Print)

2015, Number 3

<< Back Next >>

Rev Cubana Estomatol 2015; 52 (3)

Pemphigus vulgaris: a review of 12 cases

Vasconcelos AC, Miguens JSA, Figueiredo MA, Gonçalves SF, Cherubini K

Language: English
References: 26
Page: 29-33
PDF size: 217.26 Kb.


ABSTRACT

Introducción: pemphigus vulgaris is an autoimmune mucocutaneous disease, which presents at clinical examination as blisters, erosions and ulcerations of the skin and mucous membranes. Objective: the aim of this study was to review 12 cases of pemphigus vulgaris diagnosed at the Stomatology Department of "São Lucas Hospital, Pontifical Catholic University" of Rio Grande do Sul. Methods: the medical charts were analyzed considering patients age and sex; anatomic site and clinical aspect of the lesions; as well as symptoms, duration and clinical course of the disease. Results: the mean age of the patients was 46.7 years; most of cases occurred in females (75.0 %); buccal mucosa was the site most frequently affected (83.3 %), and 25 % of cases showed extraoral manifestations. Erosion/ulceration was the most prevalent clinical appearance (83.3 %), and pain occurred in 100% of cases. The mean time of development of the lesions reported by the time of the diagnosis was 12.3 months, and the mean time of follow-up was 2 years. All patients received systemic therapy with prednisone, meanwhile in 58.3 % of cases it was associated with topic therapy and in 25 %, with systemic immunosuppressive therapy. One case (8.3 %) remained in remission regardless of the treatment withdrawal. Conclusion: Pemphigus vulgaris is a disease with important morbidity, which requires the attention of the dentist as a way to achieve early diagnosis.


REFERENCES

  1. Mimouni D, Nousari CH, Cummins DL, Kouba DJ, David M, Anhalt GJ. Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris. J Am Acad Dermatol. 2003;49(6):1059-62.

  2. Scully C, Mignogna M. Oral mucosal disease: pemphigus. Br J Oral Maxillofac Surg. 2008;46(4):272-7.

  3. Sagi L, Sherer Y, Trau H, Shoenfeld Y. Pemphigus and infectious agents. Autoimmun Rev. 2008;8(1):33-5.

  4. De Simone C, Caldarola G, D'agostino M, Zampetti A, Amerio P, Feliciani C. Exacerbation of pemphigus after influenza vaccination. Clin Exp Dermatol. 2008;33(6):718-20.

  5. Jessop S, Khumalo NP. Pemphigus: a treatment update. Am J Clin Dermatol. 2008;9(3):147-54. 6. Guillen S, Khachemoune A. Pemphigus vulgaris: a short review for the practitioner. Dermatol Nurs. 2007;19(3):269-72.

  6. Darling MR, Daley T. Blistering mucocutaneous diseases of the oral mucosa a review: part 2. Pemphigus vulgaris. J Can Dent Assoc. 2006;72(1):63-6. 8. Khelifa E, Benmously R, Badri T, Debbiche A, Ben Ayed M, Mokhtar I, Fenniche S. Pemphigus vulgaris presenting as an isolated crusted plaque of the cheek. Dermatol Online J. 2009;15(6):6.

  7. Robinson JC, Lozada-Nur F, Friden I. Oral pemphigus vulgaris: a review of the literature and a report on the management of 12 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(4):349-55.

  8. Mignogna MD, Lo Muzio L, Galloro G, Satriano RA, Ruocco V, Bucci E. Oral pemphigus: clinical significance of esophageal involvement: report of eight cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;84(2):179-84.

  9. Ishii N, Maeyama Y, Karashima T, Nakama T, Kusuhara M, Yasumoto S, Hashimoto T. A clinical study of patients with pemphigus vulgaris and pemphigus foliaceous: an 11-year retrospective study (1996-2006). Clin Exp Dermatol. 2008;33(5):641-3.

  10. Perez OA, Patton T. Novel therapies for pemphigus vulgaris: an overview. Drugs Aging. 2009;26(10):833-46.

  11. Sirois D, Leigh JE, Sollecito TP. Oral pemphigus vulgaris preceding cutaneous lesions: recognition and diagnosis. J Am Dent Assoc. 2000;131(8):1156-60.

  12. Mignogna MD, Fortuna G, Leuci S, Ruoppo E, Marasca F, Matarasso S. Nikolsky's sign on the gingival mucosa: a clinical tool for oral health practitioners. J Periodontol. 2008;79(12):2241-6.

  13. Dagistan S, Goregen M, Miloglu O, Cakur B. Oral pemphigus vulgaris: a case report with review of the literature. J Oral Sci. 2008;50(3):359-62.

  14. Daneshpazhooh M, Chams-Davatchi C, Ramezani A, Moinedin F, Hemami MR. Abortive aphthous-like oral lesions: an underreported initial presentation of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2009;23(2):157-9.

  15. Mignogna MD, Leuci S, Fedele S, Ruoppo E, Adamo D, Russo G, Pagliuca R. Adjuvant high-dose intravenous immunoglobulin therapy can be easily and safely introduced as an alternative treatment in patients with severe pemphigus vulgaris: a retrospective preliminary study. Am J Clin Dermatol. 2008;9(5):323-31.

  16. Sethy PK, Khandpur S, Sharma VK. Randomized open comparative trial of dexamethasone-cyclophosphamide pulse and daily oral cyclophosphamide versus cyclophosphamide pulse and daily oral prednisolone in pemphigus vulgaris. Indian J Dermatol Venereol Leprol. 2009;75(5):476-82.

  17. Miletta N, Miller ME, Lam T, Chung KK, Hivnor C. The Management of Pemphigus Vulgaris in a Burn Intensive Care Unit: A Case Report and Treatment Review. J Burn Care Res . 2014 Feb 25. [Epub ahead of print].

  18. Hapa A, Gurpinar A, Akan T, Gokoz O. A resistant case of pemphigus gestationis successfully treated with intravenous immunoglobulin plus cyclosporine. Int J Dermatol. 2014;53(4):e269-71.

  19. Hocar O, Zidane W, Laissaoui K, Akhdari N, Amal S. Herpes infection in pemphigus. Med Mal Infect. 2009;39(1):64-5.

  20. Tran KD, Wolverton JE, Soter NA. Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients. Br J Dermatol. 2013;169(4):916-21.

  21. Moreno AC, Santi CG, Gabbi TV, Aoki V, Hashimoto T, Maruta CW. IgA pemphigus: case series with emphasis on therapeutic response. J Am Acad Dermatol. 2014;70(1):200-1.

  22. Fania L, Zampetti A, Guerriero G, Feliciani C. Alteration of cholinergic system in keratinocytes cells produces acantholysis: a possible use of cholinergic drugs in pemphigus vulgaris. Antiinflamm Antiallergy Agents Med Chem . 2012;11(3):238-42.

  23. Gürcan HM, Ahmed AR. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid. Br J Dermatol. 2009;161(4):723-31.

  24. Arnold DF, Burton J, Shine B, Wojnarowska F, Misbah SA. An 'n-of-1' placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris. Br J Dermatol. 2009;160(5):1098-102.

  25. Grando SA, Bystryn JC, Chernyavsky AI, Frusić-Zlotkin M, Gniadecki R, Lotti R, et al. Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis. Exp Dermatol. 2009;18(9):764-70.

  26. Ruocco E, Wolf R, Ruocco V, Brunetti G, Romano F, Lo Schiavo A. Pemphigus: associations and management guidelines: facts and controversies. Clin Dermatol. 2013;31(4):382-90.




2020     |     www.medigraphic.com